A look at the diabetes drugs under investigation by the U.S. Food and Drug Administration over possible risks of pancreas inflammation and cellular changes in the pancreas that occur before cancer.
DRUG CLASS: GLP-1 mimickers, taken by nearly 1 million Americans.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.